新天药业(002873.SZ)：拟对汇伦医药增资并受让其部分股权

Core Viewpoint - The company intends to invest a total of 40 million RMB in Shanghai Huilun Pharmaceutical Co., Ltd. through a combination of capital increase and share transfer, aiming to enhance its stake in the target company [1] Investment Details - The company will invest 20 million RMB to increase capital in Huilun Pharmaceutical, acquiring 2,352,941 shares at a price of 8.5 RMB per share [1] - Additionally, the company will spend 20 million RMB to acquire 2,352,941 shares from Hubei Pinghu Venture Capital Co., Ltd. [1] - The total investment in Huilun Pharmaceutical will amount to 360 million RMB after the completion of this transaction [1] Shareholding Changes - Following the transaction, the company's ownership in Huilun Pharmaceutical will rise from 14.5971% to 15.4567% [1] - The previous dilution of the company's shareholding was due to Huilun Pharmaceutical's earlier financing activities [1] Participation of Other Investors - Other investors participating in the capital increase include Yantai Tianzi Huilai Venture Capital Fund with an investment of 37 million RMB and Beijing Jinhui Feng Investment Management Co., Ltd. with an investment of 15 million RMB [1] - The total capital increase from all participating entities amounts to 72 million RMB, with no related party transactions among the investors [1]